Elucid

“Elucid... pioneered an oversubscribed $55M Series D bringing total funding to $185M.”

“Elucid... pioneers AI-powered software for precision cardiovascular diagnosis and treatment.”

“Elucid moved from FDA clearance of one product (Plaque-IQ) to review of a second (BioIntegrated FFR-CT) while raising an oversubscribed round.”